Yarrow Bioscience
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $97 | $86 | $130 | $169 |
Gross Profit | 91 | 80 | 130 | 169 |
EBITDA | -2,896 | -3,579 | -4,951 | -7,420 |
EBIT | -2,899 | -3,585 | -4,956 | -7,426 |
Net Income | -3,007 | -3,585 | -4,837 | -7,280 |
Net Change In Cash | 97 | 86 | 130 | 169 |
Free Cash Flow | -1,992 | -4,081 | -3,764 | -7,096 |
Cash | 22,925 | 24,631 | 24,027 | 19,346 |
Basic Shares | 858 | 855 | 666 | 856 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $570 | $501 | $424 | $477 |
Gross Profit | 547 | 501 | 424 | 477 |
EBITDA | -26,732 | -39,799 | -27,872 | -33,860 |
EBIT | -39,803 | -33,932 | ||
Net Income | -26,483 | -39,834 | -28,452 | -23,210 |
Net Change In Cash | 570 | 501 | 424 | 477 |
Free Cash Flow | -33,124 | -34,089 | -25,341 | -29,200 |
Cash | 24,027 | 19,926 | 30,620 | 30,908 |
Basic Shares | 855 | 851 | 205 | 63 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$2.14 |
2026-03-31 | -$4.19 |
2025-09-30 | -$8.50 |
2025-06-30 | -$6.72 |